Stocks and Investing Stocks and Investing
Thu, March 31, 2022
[ 12:00 AM ] - WOPRAI
Michael Walkley Maintained (BB) at Hold and Held Target at $7 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Blayne Curtis Downgraded (AMD) to Hold and Decreased Target to $115 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Evan Seigerman Maintained (CADL) at Buy with Decreased Target to $12 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (BRZE) at Buy with Decreased Target to $65 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Scott Berg Maintained (BRZE) at Strong Buy with Decreased Target to $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Schwartz Maintained (BRZE) at Buy with Decreased Target to $60 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Peterson Maintained (BRZE) at Buy with Decreased Target to $65 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (BRZE) at Strong Buy with Decreased Target to $60 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (BRX) at Hold with Increased Target to $28 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Stephen Powers Initiated (BRCC) at Hold and Held Target at $19 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Devin Dodge Maintained (BIP) at Buy with Increased Target to $47 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Roger Read Upgraded (BKR) to Buy and Held Target at $43 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Steven Chubak Downgraded (BK) to Hold and Held Target at $55 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (BK) at Hold with Decreased Target to $60 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $9 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (AREC) at Strong Buy with Increased Target to $4.5 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Joseph Feldman Maintained (ARHS) at Buy with Increased Target to $12 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (AMLX) at Buy with Decreased Target to $31 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Paul Sankey Upgraded (APA) to Strong Buy and Increased Target to $56 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Do Kim Initiated (AFMD) at Buy and Held Target at $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Mark Devries Maintained (AER) at Buy with Decreased Target to $72 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Christopher Stathoulopoulos Maintained (AER) at B .. y with Decreased Target to $75 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Moshe Orenbuch Maintained (AER) at Buy with Decreased Target to $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Vincent Ciantic Maintained (AER) at Buy with Decreased Target to $74 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Steven Delaney Maintained (ACRE) at Buy with Increased Target to $17 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
David Dai Initiated (ACET) at Buy and Held Target at $28 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Amit Daryanani Maintained (AAPL) at Buy and Held Target at $210 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Christopher Raymond Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Difei Yang Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Serge Belanger Downgraded (AKBA) to Hold on, Mar 31st, 2022

Serge Belanger Downgraded (AKBA) to Hold on, Mar 31st, 2022


Published on 2024-10-27 20:14:50 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Downgraded "Akebia Therapeutics, Inc." (AKBA) to Hold on, Mar 31st, 2022.

Serge, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources